{"id":"W1615542701","doi":"10.1111/j.1464-5491.2012.03624.x","title":"A randomized non‐inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with Type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin","year":2012,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Novo Nordisk; World Health Organization; Eli Lilly and Company","keywords":"Exenatide; Sitagliptin; Medicine; Metformin; Type 2 diabetes; Internal medicine; Placebo; Postprandial; Nausea; Endocrinology; Gastroenterology; Diabetes mellitus; Insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003388511,0.001793638,0.004476658,0.0005699763,0.0004930964,0.0010619,0.0009378631,0.002234778,0.008503539],"category_scores_gemma":[0.003402281,0.0009288693,0.002868087,0.0005113927,0.001956156,0.001253815,0.0005733917,0.003099031,0.0009540815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007244832,"about_ca_system_score_gemma":0.001180282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005386773,"about_ca_topic_score_gemma":0.001232171,"domain_scores_codex":[0.9979745,0.001224555,0.0001583253,0.0003234238,0.0001516502,0.0001675531],"domain_scores_gemma":[0.9967307,0.00150573,0.0006181962,0.0003799982,0.0001580166,0.0006073732],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9896169,0.003707285,0.0002640327,0.0001862332,0.0005580547,0.00002070787,0.00002807783,0.0001009174,0.00110602,0.00003911381,0.00009920962,0.004273638],"study_design_scores_gemma":[0.9530233,0.04548373,0.0007468314,0.00001208923,0.0002610204,0.00001527758,0.00001099413,0.000165081,0.0001198429,0.00006556013,0.00008931274,0.000006869852],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919939,0.001349054,0.0007662971,0.0003427466,0.0005243034,0.003387348,0.0003921431,0.00007059443,0.001173612],"genre_scores_gemma":[0.9882861,0.001021928,0.001959163,0.0009175728,0.0005540304,0.004912324,0.0005284171,0.00001959328,0.001800795],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008503539,"threshold_uncertainty_score":0.02844715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01709637035927511,"score_gpt":0.2633335422233731,"score_spread":0.246237171864098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}